Member Directory


  • 07590 815398
  • Innovation House, Discovery Park, Ramsgate Road, Sandwich, Kent, CT13 9ND

Levicept Ltd is an asset-centric UK-based biotechnology company developing a novel, safe and efficacious biological therapy (LEVI-04 [p75NTR-Fc]) for the treatment of chronic pain. We are progressing LEVI-04 to phase I clinical trials to test its efficacy and safety in patients with osteoarthritis. Levicept is developing LEVI-04 (p75NTR-Fc) modulates the clinically-validated neurotrophin pathway leading to profound, yet safe, analgesia. Clinical trials with antibodies to nerve growth factor (NGF) have demonstrated the efficacy of anti-NGF antibodies in chronic pain conditions such as osteoarthritis, back pain and cancer pain. However, anti-NGF treatment is associated with rapid progression of osteoarthritis. In pre-clinical models of osteoarthritis, administration of p75NTR-Fc provides analgesia equivalent to that achieved with anti-NGF antibody treatment, but without rapid progression of osteoarthritis.

Shared Articles

View all

Related Member

View all
Flexible Lab Solutions

Formed in February 2011, Flexible Lab Solutions create unique leasing and servicing packages for automated…

Acumen Laboratory Solutions Ltd

General laboratory instrumentation support with over 28 years’ experience supporting laboratory and medical equipment. Bespoke…